Skip to search formSkip to main contentSkip to account menu

AIDSVAX

Known as: ALVAC-HIV, vCP1521 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
nature medicine volume 21 | number 7 | july 2015 657 The search for antibodies that prevent HIV infection has been a 30-year… 
2009
2009
Some experts see hope in trial findings, but others say that the data do not back up such optimism. 
2009
2009
An announcement, by researchers from the US Army and Thailand, at a recent press conference of the first positive results from an… 
Review
2004
Review
2004
AIDSVAX, a bivalent vaccine consisting of a preparation of recombinant gp120 from two types of HIV, is being developed by VaxGen… 
2003
2003
Preliminary data from the manufacturer of AIDSVAX presented in a February press conference indicate overall disappointing results… 
Review
2001
Review
2001
AIDSVAX, a bivalent vaccine consisting of a preparation of recombinant gp120 from two types of HIV, is being developed by VaxGen… 
2000
2000
A randomized, double-blind, placebo-controlled phase I/II study of AIDSVAX (MN) was conducted among injecting drug users in… 
Review
1999